Itau Unibanco Holding S.A. Myriad Genetics Inc Transaction History

Itau Unibanco Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $3,649 - $5,170	203 New	203 $4,000
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $17,718 - $27,127	-973 Reduced 28.8%	2,405 $46,000
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $7,418 - $11,671	451 Added 15.41%	3,378 $61,000
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $70,628 - $95,508	2,927 New	2,927 $81,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.